Phase 3 Graft Function Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
Kidney TransplantDelayed Graft FunctionDGF
Alexion Pharmaceuticals, Inc.450 enrolled130 locationsNCT06830798
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
End Stage Renal DiseaseDelayed Graft FunctionDeceased Donor Kidney Transplant
Apellis Pharmaceuticals, Inc.320 enrolled1 locationNCT07020832
Recruiting
Phase 3
Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys
Kidney Transplant; ComplicationsIschemia Reperfusion InjuryDelayed Graft Function+1 more
Cliniques universitaires Saint-Luc- Université Catholique de Louvain60 enrolled1 locationNCT05430620
Completed
Phase 3
Better Evidence for Selecting Transplant Fluids (BEST-Fluids)
Delayed graft function in deceased donor kidney recipients.
Australasian Kidney Trials Network (University of Qld)800 enrolled15 locationsACTRN12617000358347